Patent · US Active

Recombinant influenza viruses with stabilized HA for replication in eggs

US11807872B2 · kind B2 · utility

10Cited by
110References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 27, 2020
Grant dateNov 7, 2023
Priority date
Expiry dateAug 27, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16151
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Modified influenza virus neuraminidases are described herein that improve viral replication, thus improving the yield of vaccine viruses. Expression of such modified neuraminidases by influenza virus may also stabilize co-expressed hemagglutinins so that the hemagglutinins do not undergo mutation or decrease the need for HA binding to cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.